Home

matrica Partina City biztosíték nik nfkb Opera előtt öböl

NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine

IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity,  Inflammation, and Cancer
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer

NFkappaB modulation ~ ViralZone
NFkappaB modulation ~ ViralZone

NF-κB in inflammation and renal diseases | Cell & Bioscience | Full Text
NF-κB in inflammation and renal diseases | Cell & Bioscience | Full Text

Frontiers | The Therapeutic Potential of Targeting NIK in B Cell  Malignancies
Frontiers | The Therapeutic Potential of Targeting NIK in B Cell Malignancies

Biomedicines | Free Full-Text | NF-κB Mutations in Germinal Center  B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
Biomedicines | Free Full-Text | NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells

NF-Kb (Nfkb) Pathway Proteins Research Tools - Creative BioMart - Creative  BioMart
NF-Kb (Nfkb) Pathway Proteins Research Tools - Creative BioMart - Creative BioMart

The non-canonical NF-κB pathway. Schematic representation of the... |  Download Scientific Diagram
The non-canonical NF-κB pathway. Schematic representation of the... | Download Scientific Diagram

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical  study | Signal Transduction and Targeted Therapy
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy

Frontiers | NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal  Integration
Frontiers | NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration

Expression Of Intracellular Components of the NF-κB Alternative Pathway  (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC  Patients | Scientific Reports
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports

Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple  Sclerosis
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis

Cancers | Free Full-Text | Targeting NF-κB Signaling for Multiple Myeloma
Cancers | Free Full-Text | Targeting NF-κB Signaling for Multiple Myeloma

Manipulation of Non-canonical NF-κB Signaling by Non-oncogenic Viruses |  SpringerLink
Manipulation of Non-canonical NF-κB Signaling by Non-oncogenic Viruses | SpringerLink

NF-kB pathway overview| Abcam
NF-kB pathway overview| Abcam

NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy

The non-canonical NF-κB pathway in immunity and inflammation | Nature  Reviews Immunology
The non-canonical NF-κB pathway in immunity and inflammation | Nature Reviews Immunology

RS, reactive species; NF-kB, nuclear factor kappa B; NIK,... | Download  Scientific Diagram
RS, reactive species; NF-kB, nuclear factor kappa B; NIK,... | Download Scientific Diagram

NF-κB - Wikipedia
NF-κB - Wikipedia

DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB  Transactivation through NIK/IKK in Human Glioma Cells | PLOS ONE
DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells | PLOS ONE

Schematic representation of Nuclear Factor-κB (NF-κB)-inducing kinase... |  Download Scientific Diagram
Schematic representation of Nuclear Factor-κB (NF-κB)-inducing kinase... | Download Scientific Diagram

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

Non-canonical NF-κB signaling pathway | Cell Research
Non-canonical NF-κB signaling pathway | Cell Research

Non-canonical NF-κB signaling pathway | Cell Research
Non-canonical NF-κB signaling pathway | Cell Research